Pre-Congress Course
Optimizing ART Outcomes
Thursday, 1 May 2025 | 0900 – 1800
Venue: Room 331, Level 3, Suntec Convention and Exhibition Centre
Course description
The evolving landscape of medically assisted reproduction (MAR) calls for improving the safety and efficacy of MAR. There is a need to individualise ART treatment especially controlled ovarian stimulation (COS) for patients. However, there are still knowledge gaps and a lack of consensus on many aspects of treatment. At the end of this workshop, participants should acquire a better understanding of the specific indications of different protocols for COS and add-on treatments during COS.
Participants will explore a range of topics, including pre-conception care to optimise fertility treatment, use of LH in IVF cycles, extremes in ovarian stimulation and challenges for ovarian stimulation in certain situations.
Course Objective
This course aims to provide attendees with the knowledge by critically reviewing the existing literature and emerging concepts. This Pre-congress will provide guidance to clinicians on
- How to distinguish between fact and fiction of COS protocols
- Be updated on best practices for COS in ART
- Be updated on the controversial aspects of COS
- To know the evidence for us of adjuvants in COS
Target audience
Reproductive medicine clinicians, gynaecologists, endocrinologists, and those wanting an overview of the topic.
This workshop is organized by the ASPIRE Reproductive Endocrinology and PCOS SIG
More information pertaining to registration can be found HERE
| Programme outline | |||
|---|---|---|---|
| 0900 – 0905 | Introduction | 5mins | Madhuri Patil (India) |
| 0905 – 1045 | Session 1: Periconception Care to Optimise Fertility Treatment Outcomes | ||
| 0905 – 0930 | Is There Evidence to Support Use of Androgens and Growth Hormone in Poor Responders? | 25 mins | Ying Cheong (United Kingdom) |
| 0930 – 0955 | Insulin Sensitisers in PCOS – When to start and When to stop? | 25 mins | Joop Laven (The Netherlands) |
| 0955 – 1020 | Lifestyle and Preconception Supplements- Do They Improve Outcomes? | 25 mins | Robert Lahoud (Australia) |
| 1020 – 1045 | Q&A Discussion | 30 mins | |
| 1045 – 1115 | Coffee Break | 30 mins | |
| 1115 – 1300 | Session 2: LH in IVF cycles | ||
| 1115 – 1140 | Serum Progesterone Level Elevation in the Late Follicular Phase: Is It Clinically Relevant? | 25 mins | Rui Wang (Australia) |
| 1140 – 1205 | Protocols for Pituitary Downregulation – What is new? | 25 mins | Jaideep Malhotra (India) |
| 1205 – 1230 | Ovarian Stimulation for IVF: LH Adds Benefit? | 25 mins | Robert Lahoud (Australia) |
| 1230 – 1300 | Q&A Discussion | 30 mins | |
| 1300 – 1400 | Lunch | 60mins | |
| 1400 – 1545 | Session 3: Addressing the “Extremes” in Ovarian Stimulation | ||
| 1400 – 1425 | Management of Poor Responders Depending on POSEIDON Groups – Does It Improve Results? | 25 mins | Madhuri Patil (India) |
| 1425 – 1450 | PCOS Patient Planned for IVF – Does AMH Have a Role in Deciding the Protocol? |
25 mins | Joop Laven (The Netherlands) |
| 1450 – 1515 | What Are the Different Roles Which GnRH Agonists Can Play in an ART Cycle? | 25 mins | Rui Wang (Australia) |
| 1515 – 1545 | Q&A Discussion | 30 mins | |
| 1545 – 1615 | Coffee Break | 30mins | |
| 1615- 1800 | Session 4: Challenges for COS During IVF | ||
| 1615 – 1640 | Optimizing Ovarian Stimulation in Women With Endometriosis | 25 mins | Ying Cheong (United Kingdom) |
| 1640 – 1705 | The Thin and Fat IVF Patient | 25 mins | Jaideep Malhotra (India) |
| 1705 – 1730 | Ovarian Stimulation in Cancer Patients | 25 mins | Madhuri Patil (India) |
| 1730 – 1800 | Q&A Discussion | 30 mins | |
| 1800 | Closing Remarks | 5mins | Robert Lahoud (Australia) Madhuri Patil (India) |
